Jillian Vaughan
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Boston Scientific at 33.6% of the total. Among family clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $47.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Curonix LLC$2K
- Spinal Simplicity, LLC$1K
- Medtronic$467
- Saluda Medical Americas, Inc.$203
- Abbott$165
- plus $350 from 11 others
What the payments were for
- Travel & lodging$3,39755%
- Food & beverage$2,80845%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 29 | $2,087 |
| Curonix LLC | 38 | $1,664 |
| Spinal Simplicity, LLC | 7 | $1,270 |
| Medtronic | 26 | $467 |
| Saluda Medical Americas, Inc. | 2 | $203 |
| Abbott | 3 | $165 |
| Stimwave Technologies Incorporated | 11 | $96 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Johnson & Johnson | 2 | $41 |
| Nalu Medical, Inc. | 2 | $33 |
| Vertex | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Merz North America, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Bioventus LLC | 1 | $15 |
| Painteq LLC | 1 | $15 |
| SPR Therapeutics, Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,297
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,202
- HA MINUTEMAN G3-R$1,059
- Evoke$189
- ETERNA$150
How this compares
$6,205 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 26 | $23,628 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 679 | $21,504 |
| OxycontinOxycodone Hcl | 42 | $18,643 |
| MovantikNaloxegol Oxalate | 31 | $15,536 |
| Pregabalin | 199 | $8,085 |
| Buprenorphine | 29 | $7,938 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 219 | $6,538 |
| Oxycodone Hcl | 278 | $6,438 |
| Morphine Sulfate ErMorphine Sulfate | 169 | $5,232 |
| SymproicNaldemedine Tosylate | 11 | $4,851 |
| Gabapentin | 251 | $3,713 |
| Tizanidine Hcl | 138 | $1,593 |
| Celecoxib | 12 | $1,157 |
| Duloxetine Hcl | 54 | $1,035 |
| Amitriptyline Hcl | 76 | $889 |
Paid to pharmacies, not to this prescriber.
Other family in Boise
- Jessica BraksiekBoise$41K
- Travis BlaserBoise$33K
- Devon MoserBoise$11K
- Jeffrey RobbinsBoise$9K
- Morgann EasonBoise$7K
- Lori RishelBoise$7K
- Heidi PetersBoise$7K
- Michelle ChinBoise$6K
- Nancy JordanBoise$6K
- Samantha BoothBoise$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.